Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: J Pain. 2020 Dec 10;22(6):655–668. doi: 10.1016/j.jpain.2020.11.008

Table 4.

Main effect estimates for pain intensity outcome measure.

Main Effects for Randomized Treatment Components
Intervention Not Used Intervention Used Relative Difference between Groups
Treatment Component Assessment Adjusted Mean (97.5% CI) Change from 1-week p value Adjusted Mean (97.5% CI) Change from 1-week p value Estimated relative difference 97.5% CI p value
SMT 4 weeks 3.28 (2.91, 3.64) −0.75 (−1.09, −0.42) <.001 3.13 (2.76, 3.51) −0.90 (−1.24, −0.56) <.001 −0.14 (−0.60, 0.32) 0.48
12 weeks 3.02 (2.61, 3.42) −1.02 (−1.39, −0.64) <.001 3.10 (2.69, 3.51) −0.93 (−1.32, −0.55) <.001 0.08 (−0.44, 0.61) 0.72
ACTex 4 weeks 3.29 (2.92, 3.66) −0.75 (−1.08, −0.41) <.001 3.13 (2.76, 3.49) −0.91 (−1.24, −0.57) <.001 −0.16 (−0.62, 0.30) 0.43
12 weeks 3.15 (2.74, 3.56) −0.88 (−1.27, −0.5) <.001 2.96 (2.56, 3.37) −1.07 (−1.44, −0.69) <.001 −0.19 (−0.71, 0.33) 0.42
MOBex 4 weeks 3.43 (3.06, 3.81) −0.60 (−0.94, −0.26) <.001 2.98 (2.61, 3.34) −1.05 (−1.39, −0.72) <0.01 −0.46 (−0.92, 0.0) 0.03
12 weeks 3.15 (2.74, 3.56) −0.88 (−1.27, −0.5) <.001 2.97 (2.56, 3.37) −1.07 (−1.44, −0.69) <0.01 −0.18 (−0.70, 0.34) 0.44

Mean values are adjusted for 1-week value of the pain intensity outcome measure and study site. P values refer to change from 1-week values.